Neuraxis, INC — Director's Dealing 2026

Mar 2, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuraxis, INC (NRXS)
CIK: 0001933567
Period of Report: 2026-01-22

Reporting Person: Miranda Adrian (CMO, SVP Science & Tech)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-22	RSU	$	A	47569	Acquired		Common Stock (47569)	Direct

Footnotes

F1: These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs vest in three equal annual installments over a three-year period.